289 related articles for article (PubMed ID: 20168077)
21. The transition model of RTK activation: A quantitative framework for understanding RTK signaling and RTK modulator activity.
Paul MD; Hristova K
Cytokine Growth Factor Rev; 2019 Oct; 49():23-31. PubMed ID: 31711797
[TBL] [Abstract][Full Text] [Related]
22. Parallels and Distinctions in FGFR, VEGFR, and EGFR Mechanisms of Transmembrane Signaling.
Sarabipour S
Biochemistry; 2017 Jun; 56(25):3159-3173. PubMed ID: 28621531
[TBL] [Abstract][Full Text] [Related]
23. KIDs rule: regulatory phosphorylation of RTKs.
Locascio LE; Donoghue DJ
Trends Biochem Sci; 2013 Feb; 38(2):75-84. PubMed ID: 23312584
[TBL] [Abstract][Full Text] [Related]
24. Unliganded EphA3 dimerization promoted by the SAM domain.
Singh DR; Cao Q; King C; Salotto M; Ahmed F; Zhou XY; Pasquale EB; Hristova K
Biochem J; 2015 Oct; 471(1):101-9. PubMed ID: 26232493
[TBL] [Abstract][Full Text] [Related]
25. Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.
Bloch E; Sikorski EL; Pontoriero D; Day EK; Berger BW; Lazzara MJ; Thévenin D
J Biol Chem; 2019 Dec; 294(49):18796-18806. PubMed ID: 31676686
[TBL] [Abstract][Full Text] [Related]
26. Pondering the mechanism of receptor tyrosine kinase activation: The case for ligand-specific dimer microstate ensembles.
Karl K; Hristova K
Curr Opin Struct Biol; 2021 Dec; 71():193-199. PubMed ID: 34399300
[TBL] [Abstract][Full Text] [Related]
27. Ligand bias in receptor tyrosine kinase signaling.
Karl K; Paul MD; Pasquale EB; Hristova K
J Biol Chem; 2020 Dec; 295(52):18494-18507. PubMed ID: 33122191
[TBL] [Abstract][Full Text] [Related]
28. Deceiving appearances: signaling by "dead" and "fractured" receptor protein-tyrosine kinases.
Kroiher M; Miller MA; Steele RE
Bioessays; 2001 Jan; 23(1):69-76. PubMed ID: 11135311
[TBL] [Abstract][Full Text] [Related]
29. Conserved roles for receptor tyrosine kinase extracellular regions in regulating receptor and pathway activity.
Gonzalez-Magaldi M; McCabe JM; Cartwright HN; Sun N; Leahy DJ
Biochem J; 2020 Nov; 477(21):4207-4220. PubMed ID: 33043983
[TBL] [Abstract][Full Text] [Related]
30. Receptor tyrosine kinases: from biology to pathology.
Choura M; Rebaï A
J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
[TBL] [Abstract][Full Text] [Related]
31. Receptor tyrosine kinase transmembrane domain interactions: potential target for "interceptor" therapy.
Najumudeen AK
Sci Signal; 2010 Sep; 3(138):jc6. PubMed ID: 20823401
[TBL] [Abstract][Full Text] [Related]
32. Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies.
Correll PH; Paulson RF; Wei X
Gene; 2006 Jun; 374():26-38. PubMed ID: 16524673
[TBL] [Abstract][Full Text] [Related]
33. Structure-function analyses of the kit receptor for the steel factor.
Blechman JM; Lev S; Givol D; Yarden Y
Stem Cells; 1993 Jul; 11 Suppl 2():12-21. PubMed ID: 7691317
[TBL] [Abstract][Full Text] [Related]
34. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.
Seubert N; Royer Y; Staerk J; Kubatzky KF; Moucadel V; Krishnakumar S; Smith SO; Constantinescu SN
Mol Cell; 2003 Nov; 12(5):1239-50. PubMed ID: 14636581
[TBL] [Abstract][Full Text] [Related]
35. The RTK Interactome: Overview and Perspective on RTK Heterointeractions.
Paul MD; Hristova K
Chem Rev; 2019 May; 119(9):5881-5921. PubMed ID: 30589534
[TBL] [Abstract][Full Text] [Related]
36. Yeast growth selection system for detecting activity and inhibition of dimerization-dependent receptor tyrosine kinase.
Gunde T; Barberis A
Biotechniques; 2005 Oct; 39(4):541-9. PubMed ID: 16235566
[TBL] [Abstract][Full Text] [Related]
37. Identifying Transmembrane Interactions in Receptor Protein Tyrosine Phosphatase Homodimerization and Heterodimerization.
Rizzo S; Thévenin D
Methods Mol Biol; 2024; 2743():195-209. PubMed ID: 38147217
[TBL] [Abstract][Full Text] [Related]
38. Cell signaling by receptor tyrosine kinases.
Lemmon MA; Schlessinger J
Cell; 2010 Jun; 141(7):1117-34. PubMed ID: 20602996
[TBL] [Abstract][Full Text] [Related]
39. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.
Shewchuk LM; Hassell AM; Ellis B; Holmes WD; Davis R; Horne EL; Kadwell SH; McKee DD; Moore JT
Structure; 2000 Nov; 8(11):1105-13. PubMed ID: 11080633
[TBL] [Abstract][Full Text] [Related]
40. Cell-Surface Expression Levels Are Important for Fine-Tuning the Performance of Receptor Tyrosine Kinase-Based Signalobodies.
Nakabayashi H; Kawahara M; Nagamune T
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28881109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
